The talk will argue trends in drug innovation in recent decades have had an underestimated causal impact on longevity improvements over the same time period.  This includes the slowdown in longevity gains since the start of this decade and, in particular, the associated decline in the rate of cardiovascular related mortality improvements.  The talk will also argue these same trends in drug innovation offer a plausible guide to future decades’ longevity trends – including the prospects of disease-modifying drugs for dementia related illnesses.

Speaker: Ivor O’Shea